Home > Term: BMS-354825
BMS-354825
A drug used to treat certain types of chronic myeloid leukemia and acute lymphoblastic leukemia. BMS-354825 is also being studied in the treatment of certain other blood diseases and types of cancer. BMS-354825 binds to and blocks BCR-ABL and other proteins that help cancer cells grow. It is a type of tyrosine kinase inhibitor. Also called dasatinib and Sprycel.
- Part of Speech: noun
- Industry/Domain: Health care
- Category: Cancer treatment
- Company: U.S. HHS
0
Creator
- Lionel M
- 100% positive feedback